Yujie Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yujie Yang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Chuanjian Lu
State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications - Ling Han
The Second Clinical Medical College of Guangzhou, University of Chinese Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications - Bin Tang
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
1 shared publication - Fanlu Liu
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication - Haiming Chen
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China
1 shared publication - Haixin Zhong
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510120, China
1 shared publication
Latest Publications
- Open Access
- 12 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1586
The Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
Psoriasis is a chronic inflammatory polygenic disease with significant impacts on skin and joints, leading to substantial treatment challenges and healthcare costs. The quest for novel therapeutic avenues has recently highlighted extracellular vesicles (EVs) due to their potential as biomarkers and therapeutic agents in autoimmune diseases, including psoriasis. EVs are nano-sized, lipid membrane-bound particles secreted by cells that have emerged as promising tools for targeted drug delivery, owing to their unique structure. This review delves into how EVs, either as mediators of cell communication or via their cargo (such as miRNA), directly participate in the pathology of psoriasis, influencing processes such as immune regulation, cell proliferation, and differentiation. Furthermore, this review explores the innovative application of EVs in psoriasis treatment, both as direct therapeutic agents and as vehicles for drug delivery, offering a novel approach to overcoming the current treatment limitations.
- 12 December 2024
- Published by MDPI AG in Pharmaceutics
- Vol. 16 (12) , 1586
Open AccessThe Role of Extracellular Vesicles in the Development and Treatment of Psoriasis: Narrative Review
Psoriasis is a chronic inflammatory polygenic disease with significant impacts on skin and joints, leading to substantial treatment challenges and healthcare costs. The quest for novel therapeutic avenues has recently highlighted extracellular vesicles (EVs) due to their potential as biomarkers and therapeutic agents in autoimmune diseases, including psoriasis. EVs are nano-sized, lipid membrane-bound particles secreted by cells that have emerged as promising tools for targeted drug delivery, owing to their unique structure. This review delves into how EVs, either as mediators of cell communication or via their cargo (such as miRNA), directly participate in the pathology of psoriasis, influencing processes such as immune regulation, cell proliferation, and differentiation. Furthermore, this review explores the innovative application of EVs in psoriasis treatment, both as direct therapeutic agents and as vehicles for drug delivery, offering a novel approach to overcoming the current treatment limitations.
- Open Access
- 28 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38586
Causal associations between psoriasis, eczema, urticaria, and mental illness: A bidirectional Mendelian randomization study of the European population
Observational studies have reported a relationship between multiple common dermatoses and mental illness. To assess the potential bidirectional causality between 3 skin disorders (psoriasis, eczema, and urticaria) and 4 psychiatric disorders (bipolar disorder, schizophrenia, major depressive disorder, and anxiety) in the European population, we used Mendelian randomization (MR) analysis, which provides definitive evidence for causal inference. Eligible single nucleotide polymorphisms were screened for dermatological and psychiatric disorders using a genome-wide association study database. We conducted bidirectional, 2-sample MR analysis using instrumental variables related to psoriasis, eczema, and urticaria as exposure factors, and bipolar disorder, schizophrenia, major depression, and anxiety as outcomes. Reverse MR analysis with bipolar disorder, schizophrenia, major depression, and anxiety as exposure and psoriasis, eczema, and urticaria as outcomes were also performed, and the causality was analyzed using inverse-variance weighting (IVW), MR-Egger, and weighted median methods. To thoroughly assess causality, sensitivity analyses were conducted using the IVW, MR-PRESSO, and MR-Egger methods. The results showed that bipolar disorder increased the incidence of psoriasis (odds ratio = 1.271, 95% confidence interval = 1.003–1.612, P = .047), heterogeneity test with Cochran Q test in the IVW showed P value > .05, ( P = .302), the MR-Pleiotropy and MR-PRESSO (outlier methods) in the multiplicity test showed P value > .05, ( P = .694; P = .441), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.060; SE = 0.139; P = .694). Major depression increased the risk of eczema (odds ratio = 1.002, 95% confidence interval = 1.000–1.004, P = .024), heterogeneity test showed P value > .05, ( P = .328), multiplicity detection showed P value > .05, ( P = .572; P = .340), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.099; SE = 0.162; P = .572). Sensitivity analyses of the above results were reliable, and no heterogeneity or multiplicity was found. This study demonstrated a statistically significant causality between bipolar disorder and psoriasis, major depression, and eczema in a European population, which could provide important information for physicians in the clinical management of common skin conditions.
- 28 June 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (26) , e38586
Open AccessCausal associations between psoriasis, eczema, urticaria, and mental illness: A bidirectional Mendelian randomization study of the European population
Observational studies have reported a relationship between multiple common dermatoses and mental illness. To assess the potential bidirectional causality between 3 skin disorders (psoriasis, eczema, and urticaria) and 4 psychiatric disorders (bipolar disorder, schizophrenia, major depressive disorder, and anxiety) in the European population, we used Mendelian randomization (MR) analysis, which provides definitive evidence for causal inference. Eligible single nucleotide polymorphisms were screened for dermatological and psychiatric disorders using a genome-wide association study database. We conducted bidirectional, 2-sample MR analysis using instrumental variables related to psoriasis, eczema, and urticaria as exposure factors, and bipolar disorder, schizophrenia, major depression, and anxiety as outcomes. Reverse MR analysis with bipolar disorder, schizophrenia, major depression, and anxiety as exposure and psoriasis, eczema, and urticaria as outcomes were also performed, and the causality was analyzed using inverse-variance weighting (IVW), MR-Egger, and weighted median methods. To thoroughly assess causality, sensitivity analyses were conducted using the IVW, MR-PRESSO, and MR-Egger methods. The results showed that bipolar disorder increased the incidence of psoriasis (odds ratio = 1.271, 95% confidence interval = 1.003–1.612, P = .047), heterogeneity test with Cochran Q test in the IVW showed P value > .05, ( P = .302), the MR-Pleiotropy and MR-PRESSO (outlier methods) in the multiplicity test showed P value > .05, ( P = .694; P = .441), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.060; SE = 0.139; P = .694). Major depression increased the risk of eczema (odds ratio = 1.002, 95% confidence interval = 1.000–1.004, P = .024), heterogeneity test showed P value > .05, ( P = .328), multiplicity detection showed P value > .05, ( P = .572; P = .340), and MR-Pleiotropy evidence showed no apparent intercept (intercept = −0.099; SE = 0.162; P = .572). Sensitivity analyses of the above results were reliable, and no heterogeneity or multiplicity was found. This study demonstrated a statistically significant causality between bipolar disorder and psoriasis, major depression, and eczema in a European population, which could provide important information for physicians in the clinical management of common skin conditions.